BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Diferuloylmethane {Curcumin} - Staphylococcus aureus M0092 |
👶
In-Vitro Antibacterial Activity of Curcumin-Loaded Nanofibers Based on Hyaluronic Acid against Multidrug-Resistant ESKAPE Pathogens. Pharmaceutics (Pharmaceutics ) Vol: 14 Issue 6 Pages: Pub: 2022 May 31 Epub: 2022 May 31 Authors Snetkov P , Rogacheva E , Kremleva A , Morozkina S , Uspenskaya M , Kraeva L , Html Article Publication |
| Diferuloylmethane {Curcumin} - Staphylococcus aureus M0092 |
👶
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 13 Issue 7 Pages: Pub: 2020 Jul 16 Epub: 2020 Jul 16 Authors Adamczak A , Ozarowski M , Karpinski TM , Html Article Publication |
| Diferuloylmethane {Curcumin} - Staphylococcus aureus M0092 |
👶
Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of a-hemolysin. Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 28254 Pub: 2016 Jun 27 Epub: 2016 Jun 27 Authors Wang J , Zhou X , Li W , Deng X , Deng Y , Niu X , Html Article Publication |
| Diferuloylmethane {Curcumin} - Staphylococcus aureus M0092 |
👶
Antimicrobial Sponge: A Polyvinyl Alcohol, Tannic Acid and Curcumin-Loaded Nanolignin Hydrogel Composite Scaffold. Gels (Basel, Switzerland) (Gels ) Vol: 11 Issue 3 Pages: Pub: 2025 Feb 26 Epub: 2025 Feb 26 Authors Anand R , Collard D , Thomann JS , Duday D , Html Article Publication |
| Diferuloylmethane {Curcumin} - Staphylococcus aureus M0092 |
👶
Natural compounds in the fight against Staphylococcus aureus biofilms: a review of antibiofilm strategies. Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1491363 Pub: 2024 Epub: 2024 Nov 20 Authors Kashi M , Noei M , Chegini Z , Shariati A , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
